CINECA IRIS Institutional Research Information System

CONTI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.363
EU - Europa 2.999
AS - Asia 1.648
SA - Sud America 55
AF - Africa 47
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.263
CN - Cina 1.045
IT - Italia 972
SE - Svezia 369
IE - Irlanda 306
DE - Germania 242
FR - Francia 219
DK - Danimarca 133
UA - Ucraina 132
FI - Finlandia 117
KR - Corea 117
GB - Regno Unito 106
AT - Austria 100
PL - Polonia 91
JP - Giappone 88
VN - Vietnam 85
IN - India 69
CA - Canada 56
HK - Hong Kong 38
SN - Senegal 38
BE - Belgio 37
IR - Iran 35
MX - Messico 34
TR - Turchia 34
AU - Australia 30
SG - Singapore 29
TW - Taiwan 29
ES - Italia 25
BR - Brasile 24
GR - Grecia 21
RU - Federazione Russa 21
NL - Olanda 19
PT - Portogallo 19
CZ - Repubblica Ceca 13
CH - Svizzera 11
HU - Ungheria 11
ID - Indonesia 10
TH - Thailandia 10
CL - Cile 9
MY - Malesia 9
CU - Cuba 8
EC - Ecuador 8
NO - Norvegia 8
PK - Pakistan 8
RO - Romania 7
CO - Colombia 6
IL - Israele 6
PE - Perù 6
EG - Egitto 5
LT - Lituania 5
SA - Arabia Saudita 5
BG - Bulgaria 4
EU - Europa 4
BD - Bangladesh 3
CY - Cipro 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
PH - Filippine 3
UZ - Uzbekistan 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
EE - Estonia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AR - Argentina 1
BT - Bhutan 1
ET - Etiopia 1
GE - Georgia 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.147
Salva come PNG Salva come JPEG
Città #
Chandler 611
Fairfield 371
Torino 332
Beijing 322
Dublin 305
Houston 255
Ashburn 222
Ann Arbor 196
Wilmington 185
Cambridge 167
Woodbridge 163
Turin 133
Seattle 124
Nyköping 115
Dearborn 106
Vienna 95
Villeurbanne 92
Jacksonville 89
Princeton 86
Medford 84
Redwood City 80
Pisa 75
Warsaw 75
Shanghai 72
Guangzhou 53
Milan 52
Hangzhou 49
Nanjing 45
Dong Ket 41
Boston 35
Fremont 29
Chengdu 28
New York 28
Washington 27
Xian 25
Wuhan 24
Ottawa 23
Taipei 23
Brussels 22
Zhengzhou 22
Boardman 19
San Diego 19
Padova 18
Seoul 18
Chongqing 17
Jinan 17
Changsha 16
Hyderabad 16
Rome 16
Silver Spring 16
Tokyo 15
Chennai 14
Phoenix 14
Shenyang 14
Hefei 13
Singapore 13
Tianjin 13
Istanbul 12
Falls Church 11
Hebei 11
Hong Kong 11
Munich 11
Norwalk 11
Athens 10
Düsseldorf 10
Villa Bartolomea 10
Chicago 9
Duncan 9
Kunming 9
Toronto 9
Ankara 8
Delhi 8
Helsinki 8
La Habana 8
London 8
Melbourne 8
Upper Marlboro 8
Verona 8
Vigliano Biellese 8
Central District 7
Changchun 7
Harbin 7
Los Angeles 7
Moscow 7
San Mateo 7
Buffalo 6
Central 6
Cisternino 6
Dresden 6
Fuzhou 6
Gravina In Puglia 6
Kuala Lumpur 6
Lima 6
Mexico 6
Oslo 6
Piemonte 6
São Paulo 6
Valenza 6
Amsterdam 5
Bangkok 5
Totale 5.484
Salva come PNG Salva come JPEG
Nome #
Breast cancer stem cell antigens as targets for immunotherapy 806
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 427
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells 379
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging 322
NK cells control breast cancer and related cancer stem cell hematological spread 291
Multi-level model for the investigation of oncoantigen- driven vaccination effect 234
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 234
A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells. 224
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 201
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 200
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 197
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 193
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells 187
Cancer stem cell antigens as targets for new combined anti-cancer therapies 176
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo 160
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice 157
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents 153
Water Soluble Melanin Derivatives for Dynamic Contrast Enhanced Photoacoustic Imaging of Tumor Vasculature and Response to Antiangiogenic Therapy 146
In Human Multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface IFN-YR2chain 144
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells 134
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 131
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 121
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 117
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 113
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 112
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential 111
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy 111
B7h triggering inhibits the migration of tumor cell lines. 108
Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice 108
Multi-level model for the investigation of oncoantigen-driven vaccination effect 107
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 106
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice 106
Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination 101
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota 97
Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. 95
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma 93
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 89
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 84
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies 84
TYPE 1 INTERFERON RECEPTOR (IFNA-R1). EXPRESSING TH17 LYMPHOCYTES ARE INCREASED DURING MS RELAPSES AND ARE SELECTIVELY INTHBITED BY IFNβ 82
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 79
A new optical imaging probe targeting α(V) β(3) integrin in glioblastoma xenografts. 75
T helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β 72
B7h triggering inhibits the migration of tumor cell lines x 72
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 72
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta 71
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 70
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study 69
B7H triggering inhibits migration of tumor cell lines 69
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 67
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes 65
Flow Cytometry for Beginners: Hints and Tips for Approaching the Very First Single-Cell Technique 65
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth 64
Iron regulates T lymphocyte sensitivity to the IFN-g/STAT1 signaling pathway in vitro and in vivo 63
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta 63
T-helper 17 lymphocytes increase during multiple sclerosis relapses and are inhibited by interferon beta 63
IL- 17 and IL-22 producing increased in multiple sclerosis relapses are MBP-specific. A multi-centre longitudinal study 62
T helper 17 Lymphocytes and multiple sclerosis: their increase in active phases of disease and the interferon beta induced inhibition 61
Retrovirus-mediated targeting of the Insulin-like Growth Factor-1 Receptor reinstates T lymphocytes sensitivity to the apoptotic effect of IFN-g 59
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 58
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins 58
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 57
Ready for a new saga? Th17 and not Th1 are selectively increased in active multiple sclerosis and undergo apoptosis with interferon beta 56
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 54
JAK2 is overexpressed in human multiple sclerosis Th17 cells andstabilizes cell surface expression of IFN-gammaR2. 53
MBP-Specific Th17 Lymphocytes selectively increase during MS relapses. A multicenter longitudinal Study 51
In the absence of Insulin-like Growth Factor (IGF)-1 signaling, Interferon-gamma (IFN-g) inhibits the growth of human malignant T cells 51
Iron chelation restores human T cells sensitivity to the IFN-g/STAT1 signaling pathway. Jaks and Stats: development to disease 49
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 48
Interleukin-17 t lymphocyte production correlates with disease activity in Multiple Sclerosis 47
Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. 47
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? 44
Ready for a new saga? Th17 and not Th1 are selectivly increate in active multiple sclerosis and undergo apoptosis with interferon beta 42
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy 41
The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells 41
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 39
Longitudinal analysis of IL-17 and/or IL-22 producing CD4+ T lymphocytes in relapsing remitting multiple sclerosis 38
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 30
JAK2 is overexpressed in human multiple sclerosis Th17 cells and stabilizes cell surface expression of IFN-gammaR2 30
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy 29
Tissue memory relies on stem cell priming in distal undamaged areas 27
Modulation of STAT1 signaling pathway by Interferons (IFNs) in human T helper (Th)17 lymphocytes 27
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 26
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models 19
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 19
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment 16
A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes 13
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source 13
A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation 11
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models 11
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease 10
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy 10
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine 2
Totale 9.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.757
article - articoli 0
book - libri 0
conference - conferenze 4.252
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019368 0 0 0 0 0 0 0 0 0 76 196 96
2019/20201.465 94 76 97 170 99 228 140 114 151 133 90 73
2020/20211.361 80 69 88 63 98 89 144 79 180 150 133 188
2021/20221.651 100 93 82 155 109 111 110 102 79 183 267 260
2022/20231.918 195 146 53 187 139 458 155 145 179 49 134 78
2023/2024993 130 153 108 87 114 129 93 88 18 73 0 0
Totale 9.489